Advanced Non-Clear Cell Renal Cell Carcinoma

Ask The Expert About Non-Clear Cell Renal Cell Carcinoma (nccRCC) ManagementПодробнее

Dr McGregor on the Updated NCCN Guidelines for Non–Clear Cell RCCПодробнее

Clearing Up Non-Clear Cell Renal Cell Carcinoma ManagementПодробнее

myTRIAList Clinical Trial: STELLAR-304Подробнее

Renal Cell Carcinoma | Investigator Perspectives on Available Research Findings and Challenging Q...Подробнее

GU Cancer | Advanced treatment | Kidney Cancer | Renal cancer | Targeted therapy | ImmunotherapyПодробнее

News: A Tailored Approach: Evidence-Based Management Strategies for Advanced/Metastatic ncc-RCCПодробнее

2024 Kidney Cancer Patient and Caregiver Education Symposium (July 27, 2024)Подробнее

FORTUNE: Tivozanib Plus Nivolumab for Advanced nccRCCПодробнее

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationaleПодробнее

UROwebinar: Management of Metastatic kidney cancerПодробнее

KEYNOTE-B61: first-line lenvatinib + pembrolizumab in non-clear cell RCCПодробнее

Review of the Data of Frontline Treatment for Non-Clear Cell Kidney CancerПодробнее

August Researcher of the Month - Alexander Chehrazi-Raffle, MD, City of HopeПодробнее

Cohort 1 LITESPARK-003: belzutifan + cabozantinib 1L treatment for advanced RCCПодробнее

Biology of Non-clear Cell Renal Cancer Subtypes: KCRS23 Session One | KidneyCANПодробнее

Promising results of cabozantinib plus nivolumab in non-clear cell RCCПодробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Advanced Kidney Cancer: What the Urologist Needs to KnowПодробнее